Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution.
about
Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and developmentEvaluation of the lipophilicity of selected sunscreens--a chemometric analysis of thin-layer chromatographic retention data.Approaching 'Kit-Type' Labelling with (68)Ga: The DATA Chelators.Interpreting physicochemical experimental data sets.Quantitative structure-retention relationships for ionic and non-ionic compounds in biopartitioning micellar chromatography.From physicochemistry to absorption and distribution: predictive mechanistic modelling and computational tools.The performance of 1-ethyl-3-methylimidazolium tetrafluoroborate ionic liquid as mobile phase additive in HPLC-based lipophilicity assessment.Evaluation of [18F]-ATRi as PET tracer for in vivo imaging of ATR in mouse models of brain cancer.In silico prediction of human serum albumin binding for drug leads.A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanismInvestigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approach.Docosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse BrainAlternative methods for estimating common descriptors for QSAR studies of dyes and fluorescent probes using molecular modeling software: 1. Concepts and procedures.Mini review on blood-brain barrier penetration of pyridinium aldoximes.Factors affecting separation and detection of bile acids by liquid chromatography coupled with mass spectrometry in negative mode.Exploring the Influence of the Aromaticity on the Anticancer and Antivascular Activities of Organoplatinum(II) Complexes.Advances in immobilized artificial membrane (IAM) chromatography for novel drug discovery.Cellular accumulation, lipophilicity and photocytotoxicity of diazido platinum(IV) anticancer complexes.High mitochondrial accumulation of new gadolinium(III) agents within tumour cells.Physicochemical properties and photodynamic activity of novel derivatives of triarylmethane and thiazine.Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity.Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.Lipophilicity and biomimetic properties to support drug discovery.A method for measuring the lipophilicity of compounds in mixtures of 10.Retooling manganese(III) porphyrin-based peroxynitrite decomposition catalysts for selectivity and oral activity: a potential new strategy for treating chronic pain.Synthesis and RP HPLC studies of biologically active semicarbazides and their cyclic analogues 1,2,4-triazol-3-ones.Novel compstatin family peptides inhibit complement activation by drusen-like deposits in human retinal pigmented epithelial cell cultures.High-throughput method for lipophilicity measurement.Quantification of Lipophilicity of 1,2,4-Triazoles Using Micellar Chromatography.Tuning chloride binding, encapsulation, and transport by peripheral substitution of pseudopeptidic tripodal small cages.Comprehensive evaluation of lipophilicity of biogenic amines and related compounds using different chemically bonded phases and various descriptors.Using molecular simulation to predict solute solvation and partition coefficients in solvents of different polarity.Prediction of pesticides chromatographic lipophilicity from the computational molecular descriptors.Orthogonal chromatographic descriptors for modelling Caco-2 drug permeability.Anti-leishmanial and structure-activity relationship of ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives.Synthesis and pharmacological evaluation of 99mTc-labeled imidazolyl-containing diphosphonic acid as a novel bone imaging agent.Substituted pyrazinecarboxamides: synthesis and biological evaluation.Radiosynthesis and evaluation of 1-substituted 3-(2,3-dihydro-1H-inden-2-yl)-6-(1-ethylpropyl)-(3R,6R)-2,5-piperazinedione derivatives as PET tracers for imaging the central oxytocinergic system.Development of the first sphingomyelin biomimetic stationary phase for immobilized artificial membrane (IAM) chromatography.
P2860
Q28477404-F9B2DD1B-752C-4B2C-AC10-35B83C7C3BD6Q30844124-DC91E0E7-7813-46B7-A139-CDD12E7043CAQ30938260-11C38494-72C1-4EE1-B9E3-E63CC4C9D2FCQ30967921-F25B58D2-A0E6-453C-9FFC-C0EDC15E7025Q33208498-AFC204A5-3B47-45B2-B935-7631DE889AE7Q33254667-AB27AD86-5654-43D7-9837-49738922C829Q33673038-D77EF03C-D5A6-4EFF-B6FF-FA6AC7BB4C0EQ33925006-7F237076-B379-4015-BE05-1BB3C2FB9240Q34609144-CAD5FDBB-8810-49D0-84FD-2A0B02D05B31Q35154370-179B085E-BC9E-4A7F-93A6-84D1868088A2Q36017297-E34A622B-530B-4314-A8CA-0B504905BC51Q36452404-0C2CCB99-81E3-4FD6-8C62-97B2C2B7A858Q37256184-350CB10D-83C7-422A-8F53-8B4BA20E45D4Q38125490-C7BD4F92-FA20-4805-A470-4F04FAFF6E0FQ38257801-7DBE1684-1773-4782-956D-E04BC7A39919Q38687985-2ACC326F-AE16-4522-A429-97C916C8A57EQ38712938-7CD9419A-8213-4E90-A903-3A1AFD961852Q38769803-AAC6F6EA-F1C5-4107-91C3-F04FD62141C5Q38993842-3AD38D7C-0B50-47E6-B840-72F9CE324489Q39042049-DDBE8AA5-CE51-46A1-97DD-004A8D0B9FF0Q39180926-4E01C7EC-0666-41E2-A721-2F94C642EB7CQ39235908-5F94762E-392E-4C7A-A417-03A20A0B9AE2Q39298980-AE0A0D7D-AABE-4E87-A448-49AC5935AC7AQ39394394-2744B6DE-BC91-4194-B4D3-1D45C7B73398Q39779913-6DC0788B-0028-4BEF-B4D1-33F4DB08BD3CQ39864101-8BB56725-61D9-4844-8F04-334A95FFECEBQ41257769-D51F454C-0497-4673-9769-AAF972521B36Q41849353-41F93B90-F6BE-4449-99CC-5BCDEE1596FBQ42076847-6F241522-9983-4F00-853D-04279EB557D0Q42134622-23F0A654-265E-4DB1-B671-590FC3A2FDDFQ42681665-4C52A5A9-97F5-4E21-9BB1-B27D2C915071Q44539249-18D582DE-BAEB-4761-83ED-A597FD458507Q44668468-D0BFBF63-BFC9-4B8E-98DE-A02DFEF03301Q45400635-7ADBB27F-F885-4A95-944A-45322421EC77Q45865440-B0EFB66A-B5FF-4355-AFE4-67C4BDB86089Q46160454-BDD9B0BA-B03E-45DC-90BD-B6C553CBAE25Q46205142-4AE17D88-1E2F-4320-9017-3AA44070A127Q46930090-FBEFD216-ED5C-4CE2-9CB7-4D305A4C5AC8Q47798526-01265E74-5E63-4B94-9722-F1EDEA7E4572Q48787078-87FB8329-AB91-4911-95D8-E42F33A42046
P2860
Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Application of high-performanc ...... model biological distribution.
@ast
Application of high-performanc ...... model biological distribution.
@en
Application of high-performanc ...... model biological distribution.
@nl
type
label
Application of high-performanc ...... model biological distribution.
@ast
Application of high-performanc ...... model biological distribution.
@en
Application of high-performanc ...... model biological distribution.
@nl
prefLabel
Application of high-performanc ...... model biological distribution.
@ast
Application of high-performanc ...... model biological distribution.
@en
Application of high-performanc ...... model biological distribution.
@nl
P1476
Application of high-performanc ...... model biological distribution
@en
P2093
Klára Valkó
P304
P356
10.1016/J.CHROMA.2003.10.084
P407
P50
P577
2004-05-01T00:00:00Z